HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beth Hollister Selected Research

JNJ 28871063

2/2008Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beth Hollister Research Topics

Disease

6Neoplasms (Cancer)
08/2010 - 10/2002
1Residual Neoplasm
08/2010
1Retinoblastoma (Glioblastoma, Retinal)
10/2005
1Neoplasm Metastasis (Metastasis)
09/2004
1Carcinoma (Carcinomatosis)
10/2002
1Melanoma (Melanoma, Malignant)
10/2002

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
03/2006 - 10/2002
2Phosphotransferases (Kinase)IBA
02/2008 - 09/2004
1Monoclonal AntibodiesIBA
08/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2010
1Blocking AntibodiesIBA
08/2010
1Complement System Proteins (Complement)IBA
08/2010
1JNJ 28871063IBA
02/2008
1Tyrosine (L-Tyrosine)FDA Link
02/2008
1PolymersIBA
03/2006
1IT-101IBA
03/2006
1Irinotecan (Camptosar)FDA LinkGeneric
03/2006
1CamptothecinIBA
03/2006
1Aurora KinasesIBA
10/2005
1JNJ-7706621IBA
10/2005
1CDC2 Protein Kinase (Protein p34cdc2)IBA
10/2005
1Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2005
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2005
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2004
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
09/2004
1Paclitaxel (Taxol)FDA LinkGeneric
09/2004
14- (4- (1- Amino- 1- methylethyl)phenyl)- 2- (4- (2- morpholin- 4- yl- ethyl)phenylamino)pyrimidine- 5- carbonitrileIBA
09/2004
1Angiogenesis InhibitorsIBA
09/2004
1SuspensionsIBA
10/2002
1rubitecanIBA
10/2002

Therapy/Procedure

2Therapeutics
08/2010 - 09/2004
1Duration of Therapy
08/2010
1Aftercare (After-Treatment)
09/2004